Moderna Earnings
NASDAQ: MRNAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Thu, Nov 5, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.10
Moderna earnings summary
Moderna is scheduled to report Sep/2026 earnings on Nov 5, 2026, with analysts expecting EPS of $-1.10. In its most recent report on Jul 31, 2026 (Q2 2026), MRNA posted EPS of $-1.97. Revenue for the quarter was $145.0 million.
Across the last 16 reports, MRNA shares moved an average of 8.1% (in either direction) in the first trading session after results, rising 6 times and falling 10 times.
Summary generated from market data by MetaCap's automated system. Methodology
MRNA earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Jul 31, 2026 | — | $-1.97 | — | +7.9% |
| May 1, 2026 | — | $-3.40 | — | +19.8% |
| Feb 20, 2026 | — | $-2.10 | — | +7.4% |
| Nov 6, 2025 | — | $-0.51 | — | +0.9% |
| Aug 1, 2025 | — | $-2.13 | — | -5.4% |
| May 1, 2025 | — | $-2.52 | — | -12.2% |
| Feb 21, 2025 | — | $-2.91 | — | -12.9% |
| Nov 7, 2024 | — | $0.03 | — | -21.3% |
| Aug 1, 2024 | — | $-3.33 | — | -1.9% |
| May 2, 2024 | — | $-3.07 | — | -6.2% |
| Feb 23, 2024 | — | $0.63 | — | -1.5% |
| Nov 3, 2023 | — | $-9.53 | — | -9.6% |
| Aug 3, 2023 | — | $-3.62 | — | -6.2% |
| May 4, 2023 | — | $0.19 | — | -5.6% |
| Feb 24, 2023 | — | $3.77 | — | +2.8% |
| Nov 3, 2022 | — | $2.53 | — | +8.1% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.